federal_register: E8-13353
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-13353 | Oral Dosage Form New Animal Drugs; Deracoxib | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for the addition of a 50-milligram size deracoxib tablet which is used for the control of pain and inflammation in dogs. | 2008-06-13 | 2008 | 6 | https://www.federalregister.gov/documents/2008/06/13/E8-13353/oral-dosage-form-new-animal-drugs-deracoxib | https://www.govinfo.gov/content/pkg/FR-2008-06-13/pdf/E8-13353.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for the addition of a... |